Added to YB: 2026-09-09
Pitch date: 2026-09-06
ERF.PA [neutral]
Eurofins Scientific SE
-1.6%
current return
Author Info
No bio for this author
Company Info
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
Market Cap
EUR 12.6B
Pitch Price
EUR 72.36
Price Target
N/A
Dividend
0.99%
EV/EBITDA
9.79
P/E
28.43
EV/Sales
2.24
Sector
Life Sciences Tools and Services
Category
turnaround
Top 5 European Stocks, September 2026: My Highest-Conviction Picks - Eurofins Scientific, the world’s leading testing company finally emerging from its investment cycle
ERF.PA (monitor): Eurofins is emerging from its 2023-2027 investment cycle: H1 2026 adjusted EBITDA margin rose 130 basis points to 23.7%, FCFF increased 46% to €403 million, and net operating capex fell to 3.9% of revenue. However, at €72.54 and roughly 18x expected 2026 earnings, the turnaround is partly recognized while organic growth remains 2.7% versus a 6.5% long-term target. Wait for a €62-65 entry point that better compensates for execution and governance risks.
Read full article (3 min)